Anzeige
❌
Mehr »
Mittwoch, 30.09.2026 - Börsentäglich über 12.000 News
Operation Vivaldi verändert die Kriegsführung: Bodendrohnen-Aktie mit Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
28.08.Evonik Invests $108M in Vancouver GMP Facility
27.08.Genezen to Offer Access to 4basebio Synthetic DNA Platform for Viral Vectors
27.08.Biohaven, SK Biopharmaceuticals Ink Licensing Pact for Next-Gen Epilepsy Candidate
27.08.Neuland, Gland Pharma Partner on Sterile API Manufacturing
27.08.Psilera Names Allyson Gage VP of Clinical Development
27.08.Symbiosis Appoints Jay Chima as VP, Business Development
27.08.Circio, Full Circles Partner on In Vivo Cell Therapy
26.08.Artis BioSolutions Opens Genetic Medicines Center of Excellence in Spain
26.08.Körber Releases PAS-X MES 3.4.2 for Pharma Manufacturing
26.08.Lonza Names Samanta Cimitan Chief Commercial Officer
25.08.Hovione Completes Expansion of Loures, Portugal Tablet Manufacturing Center
25.08.Celltrion Launches 300-mg Strength Omlyclo in Europe
25.08.McKesson to Acquire Precision Medicine Group in $2.25B Deal
25.08.Lundbeck, Eversana Expand AI Commercialization Partnership
25.08.Hanmi Pharm, Genentech Ink $2.3B Obesity Drug Licensing Deal
25.08.Cambrex High Point Site Clears FDA, PMDA, TGA Inspections
24.08.The Emmes Group Names Rama Kondru CEO
24.08.Insmed's Brinsupri Approved in Japan to Treat NCFB, Joining US and Europe
24.08.Novotech Opens Tokyo Office, Strengthening Japan Presence
24.08.Ashland Launches Permexa Sodium Caprate High-Performance Intestinal Permeation Enhancer
24.08.Barentz Appoints Matt Mitchell as Global VP, Pharmaceuticals
24.08.AN2 Therapeutics Names Dr. Cameron Trenor as Chief Medical Officer
24.08.Werewolf, Ambros to Merge in All-Stock Deal
21.08.Alvotech, Lotus Ink Biosimilar Licensing and Commercialization Pact in US, Asia
21.08.MedPharm Expands End-to-End Proteomic Analysis Capabilities with Olink Certification